CUDC-101 is a small-molecule inhibitor of histone deacetylase (HDAC), EGFR (epidermal growth factor receptor), and HER2 ( human epidermal growth factor receptor 2) inhibitor for the treatment of cancer. Reagent grade, for research purpose.
Usually ships within 24 hours.